Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0265264 (
HOS
)
1,119
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sphingosine-1-phosphate is a bioactive lipid and a signaling molecule integrated into many physiological systems such as differentiation, proliferation and migration. In mammals
S1P
acts through binding to a family of five trans-membrane, G-protein coupled receptors (S1PRs) whose complex role has not been completely elucidated. In this study we use zebrafish, in which seven
s1prs
have been identified, to investigate the role of
s1pr1
. In mammals
S1PR1
is the most highly expressed
S1P
receptor in the developing heart and regulates vascular development, but in zebrafish the data concerning its role are contradictory. Here we show that overexpression of zebrafish
s1pr1
affects both vascular and cardiac development. Moreover we demonstrate that
s1pr1
expression is strongly repressed by miR-19a during the early phases of zebrafish development. In line with this observation and with a recent study showing that miR-19a is downregulated in a zebrafish
Holt-Oram
model, we now demonstrate that
s1pr1
is upregulated in
heartstring
hearts. Next we investigated whether defects induced by
s1pr1
upregulation might contribute to the morphological alterations caused by Tbx5 depletion. We show that downregulation of
s1pr1
is able to partially rescue cardiac and fin defects induced by Tbx5 depletion. Taken together, these data support a role for
s1pr1
in zebrafish cardiovascular development, suggest the involvement of this receptor in the Tbx5 regulatory circuitry, and further support the crucial role of microRNAs in early phase of zebrafish development.
...
PMID:Post-transcriptional Modulation of Sphingosine-1-Phosphate Receptor 1 by miR-19a Affects Cardiovascular Development in Zebrafish. 2992 49